Prochlorperazine
Product Images NDC 54348-114

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prochlorperazine (NDC 54348-114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmpak, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label15 (Label15)

Label for PROCHLORPERAZINE TABS 10MG #2 manufactured by CADISTA PHARM, with instructions for oral tablet use and a warning about possible drowsiness. The label includes storage instructions, lot number, expiration date, NDC 54348-114-02, and a bilingual instruction in English and Spanish.*

FDA Label Image

Label16 (Label16)

Label for PROCHLORPERAZINE tablets 10 mg, pack of 4, manufactured by Cadista Pharm. The label includes dosage instructions to take one tablet orally every 6 hours as needed for nausea, with a note on possible drowsiness. It shows storage temperature (68-77°F), lot number, expiration date (6/19/20), and mentions PharmPak, Inc. as the packer located in San Rafael, CA.*

FDA Label Image

Structure Of Prochlorperazine (Structure)

Chemical structure diagram of prochlorperazine, showing its molecular composition including a chlorine atom and piperazine ring. The structure also includes two molecules of an acid, likely indicating a salt form often used in pharmaceutical formulations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.